Pluristem Therapeutics Inc (PSTI)

[zzaatt]

I just can't believe the PPS at this point

It's somewhat surprising, and one can
only speculate as to why, but my sense is that anyone who thinks
that current "value" of an early/middling stage biotech, with no
product, will be accurately reflected in the PPS, way overestimates
the "wisdom" of the market.

The technology is very new and exotic, the company is in Israel,
it's very small, and the CEOs are called "yaky" and "zami".
I think the latter might be the most decisive! (LOL)

As for me however, the dribs and drabs of data coming in from
researchers/physicians, all of which seem to be VERY positive,
(see below) is the most convincing.

I'm especially impressed with PLX-R18's very interesting feature,
that is, that you can inject it even before radiation (or after for that
matter) and the cells will produce the therapeutic proteins as needed (or not).
That alone is astonishing, I don't know of any other class of medications
that can do that.

All of the above definitely keep me very interested.

Dr. Tobias Winkler of the Center for Musculoskeletal Surgery & Julius Wolff Institute Berlin, Charité, who served as Senior Scientist on the completed Phase I/II orthopedic study, commented, “In our studies PLX cells demonstrated the potential to improve overall muscle functionality, with an impressive magnitude of effect. An additional orthopedic PLX indication has a promising potential.”